In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1286.5 with a total volume of ...

More than a million people living in Ontario visited a food bank in the last year as food prices soared across the province, ...

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its 2024 Investor Day. While these events are often catalysts for stock, ...

Moderna’s stock has seen an extended downtrend since peaking above $480 in late 2021. After crashing to below $70 in November last year, the stock experienced a strong medium-term rally that took it ...

Shares of Moderna tumbled early Thursday after the vaccine developer said it was cutting research and development spending and pushed back its time frame for breaking even.

Gold’s function as a store of value has stood the test of time, helping owners maintain their purchasing power over thousands of years. Click to read.

Focuses on ten product approvals through 2027Expects to submit next-generation COVID vaccine for approval in 2024Expects to submit flu/COVID combination vaccine for approval in 2024Announces positive ...

Moderna, the biotech company known for developing one of the COVID-19 vaccines, plans to cut $1.1 billion in expenses by 2027 ...

Delving into the details, we found 45% of traders were bullish, while 36% showed bearish tendencies. Out of all the trades we ...

Shares 20+ Year Treasury Bond ETF is breaking higher in anticipation of the rate cut cycle. Click here to see why TLT is a ...

The vaccine manufacturer Moderna reported in the journal Cell that a messenger RNA-based mpox vaccine that it is developing ...

You can display the asset rates in 27 different time frames: Tick chart (the most precise data), Intraday (18 time frames available, from 1 to 720 minutes - that is 12 hours), Daily, Weekly ...